Electra Therapeutics
Electra Therapeutics is a biotech company in South San Francisco, United States, founded in 2018. It has raised $267.0M across 2 rounds, most recently a $183.0M Series C in October 2025.
Pioneering next-generation immunology therapeutics.
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- electra-therapeutics.com
- Total Funding
- $267.0M
- Last Round
- $183.0M Series COct 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 7 investors for this company. The full record is or through the API.
About
Electra Therapeutics is a clinical-stage biotechnology company in South San Francisco developing antibody therapies against signal regulatory proteins (SIRP) for immunological diseases and cancer. Lead candidate ELA026, a monoclonal antibody that targets SIRP on myeloid and T cells to deplete pathological immune cells, is advancing into a global pivotal Phase 2/3 study in secondary hemophagocytic lymphohistiocytosis (sHLH), a hyperinflammatory disease with no approved treatment. Founded in 2018 as the first company launched from Star Therapeutics, Electra raised an $84 million Series B in February 2022 and an oversubscribed $183 million Series C in October 2025 co-led by Nextech and EQT Life Sciences, with Sanofi, HBM Healthcare Investments, Mubadala Capital, and OrbiMed participating. Proceeds also fund expansion of ELA026 into hematologic cancers and a second SIRP program.
Summary
It lists 11–50 employees. It has raised $267.0M in total across 2 rounds, most recently a $183.0M Series C round in Oct 2025. Investors include EQT AB, Nextech Invest and Westlake Village BioPartners.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2025
Sign up to see all 2 events
Funding: Series B through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/electra-therapeutics"><img src="https://indexed.vc/api/badge/company/electra-therapeutics" alt="Electra Therapeutics on Indexed.vc" width="260" height="76" /></a>